HealthcareDec 2, 2022

Metagenomic Sequencing Market

By Segment, By Region, And Segment Forecasts, 2016 – 2027

Vertical: HealthcareBase Year: 201911 Sections

Book Demo

Executive Summary

Metagenomic Sequencing Market — Snapshot

Market Size (2016)
2016
$661.38M
Projected (2027)
2027
$3.39B
CAGR (2016–2027)
16.0%
16.0%
Key Players
108+

Metagenomic sequencing is a modern genomics technique that helps in the analysis of microbial DNA from various environmental communities. Metagenomics sequencing allows researchers to analyze genes in any given sample. This method enables access to bacterial diversity and identifies the presence of microbes in various environments.

Factors that drive the market growth are the wide range of applications of metagenomics in various fields, rising government funding and initiatives for growth of sequencing techniques, and declining cost of sequencing. However, unfavorable regulatory policies are hampering the growth of the market.

Key Insight

The Metagenomic Sequencing Market market is projected to grow at a CAGR of 16.0% from 2016 to 2027.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 4 regions: Europe, Asia Pacific, Middle East and Africa, Americas.
Market Segmentation: The market is analyzed across 4 segments: Reagents & Consumables, Services, Instruments, Analysis and Data Interpretation Solutions. Forecasts are provided for each segment from 2016 to 2027.
Competitive Landscape: 108 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Metagenomic Sequencing Market — Growth Trajectory

Scope of the Study

The scope of the global metagenomic sequencing market study includes market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on product & service, application, technology, and region.

Research Objective

To provide a comprehensive analysis of the global metagenomic sequencing market and its sub-segments, thereby providing a detailed structure of the industry To provide detailed insights into factors driving and restraining the growth of the global metagenomic sequencing marketTo estimate the market size of the global metagenomic sequencing market where 2017 to 2018 would be the historic period, 2019 shall be the base year, and 2020 to 2027 will be the forecast period for the studyTo provide region-wise market value analysis for various segments of the global metagenomic sequencing marketTo provide strategic profiling of key companies (manufacturers and distributors) present across the globe and comprehensively analyze their competitiveness/competitive landscape in this marketTo provide a distribution chain analysis/value chain for the global metagenomic sequencing market

Metagenomic Sequencing Market — Growth Trajectory

Reagents & Consumables

Services

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

Products & Services is broken down into: Reagents & Consumables, Services, Analysis and Data Interpretation Solutions, Instruments.
Technology is broken down into: 16S rRNA-Based Sequencing, Shotgun Metagenomics Sequencing, Metatranscriptomics, De Novo Assembly.
Application is broken down into: Biotechnology, Infectious Disease Diagnosis, Biofuel, Agriculture, Gut Microbe Characterization, Environmental Remediation, Others.

Geographic Analysis

Regional market breakdown

Europe Europe market size reached $148.17M in 2016 and is projected to reach $779.82M by 2027, growing at a CAGR of 16.3%.
Asia Pacific Asia Pacific market size reached $82.84M in 2016 and is projected to reach $429.80M by 2027, growing at a CAGR of 16.1%.

Middle East and Africa Middle East and Africa market size reached $38.48M in 2016 and is projected to reach $105.95M by 2027, growing at a CAGR of 9.6%.
Americas Americas market size reached $391.89M in 2016 and is projected to reach $2.08B by 2027, growing at a CAGR of 16.4%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Metagenomic Sequencing Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

Base Year
2019
Historical Period
2016 – 2019
Forecast Period
2019 – 2027
Primary Interviews
150+

Research Process

Historical data (2016–2019) and forecast period (2019–2027)

1

Problem Definition

Market scoping
Objective setting
Framework design

2

Secondary Research

Literature review
Data mining
Trend analysis

3

Primary Research

Expert interviews
Field visits
Surveys

4

Data Analysis

Quantitative modeling
Statistical testing
Validation

5

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Metagenomic Sequencing Market — Competitive Analysis

Threat of New Entrants

The threat of new entrants in the global metagenomic sequencing market is medium. Any company trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. The market is also characterized by a high degree of brand loyalty, where establishing a brand name is difficult for newcomers. The rise in the demand for metagenomic sequencing technology owing to its potential growth in the coming future is expected to attract the currently established and other manufacturers to focus more on this segment. Furthermore, the cost involved in research and development (R&D) is comparatively high, which does not comfort the new entrants to enter the market easily.

Bargaining Power of Suppliers

The suppliers in the global metagenomic sequencing market are raw material suppliers. There are various suppliers present in the global metagenomic sequencing market. At present, there are a number of suppliers present in the market owing to the high demand, increasing government support, and the availability of huge opportunities for the development of the market. The market is dominated by a few existing significant companies, and they hold the major share in the global market and have the capability of fluctuating the costs of the products. However, the switching cost of these suppliers is low to medium because suppliers tend to enter into long-term associations, partnerships, and deals with the other product manufacturing companies. Therefore, the overall bargaining power of suppliers in the global advanced wound therapy devices market is medium.

Threat of Substitutes

The threat of substitutes in the global metagenomic sequencing market is medium, as it is still an upcoming technology. Although there are no direct threats, other genome sequencing technologies take up a significant share.

Bargaining Power of Buyers

The bargaining power of buyers is moderate in the global metagenomic sequencing market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising prevalence of cancer. Additionally, the presence of providers is also increasing, which makes the bargaining power of buyers moderate due to the low switching costs.

Intensity of Rivalry

The degree of competition in the global metagenomic sequencing market is high. Companies involved in the metagenomic sequencing market are trying to introduce more advanced products, for differentiating their product from their rivals. Moreover, manufacturers also focus on the enhanced safety and quality of the products to increase the demand for these products in developed countries and developing regions. To overcome the competition, players are engaged in partnering with established organizations and welcoming tie-ups.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Metagenomic Sequencing Market.

Regional Market Size (USD Mn)

Market estimates by geography (2027)

USD Mn

InsightAmericas leads with $2.08B by 2027.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2016	2019	2027	CAGR	SHARE
Europe	$148.17M	$354.95M	$779.82M	16.3%	23%
Asia Pacific	$82.84M	$196.91M	$429.80M	16.1%	13%
Middle East and Africa	$38.48M	$68.09M	$105.95M	9.6%	3%
Americas	$391.89M	$942.76M	$2.08B	16.4%	61%
Total	$661.38M	$1.56B	$3.39B	16.0%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2027)

Reagents & Consumables

Services

Instruments

Analysis and Data Interpretation Solutions

0618123518532470

Reagents & Consumables66%
Services16%
Instruments13%
Analysis and Data Interpretation Solutions5%

Total Market Size

$3.39B

Market by Segment (2027)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Reagents & Consumables	$2.25B	16.0%	40%
Services	$534.71M	16.0%	89%
Instruments	$452.82M	16.0%	89%
Analysis and Data Interpretation Solutions	$161.22M	16.0%	85%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

Metagenomic Sequencing Market — Key Findings

Analytical insights on Metagenomic Sequencing Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Metagenomic Sequencing Market market is projected to reach $3.39B by 2027, growing at 16.0% CAGR. The Reagents & Consumables segment holds the largest share.

Market Dynamics

Metagenomic sequencing is a modern genomics technique that helps in the analysis of microbial DNA from various environmental communities. Metagenomics sequencing allows researchers to analyze genes in any given sample. This method enables the access of bacterial diversity and identifies the presence of microbes in various environments.

Factors that drive the market growth are the wide range of applications of metagenomics in various fields, rising government funding and initiatives for growth of sequencing techniques, and declining cost of sequencing. However, unfavorable regulatory policies are hampering the growth of the market.

Market Drivers

Genomics analyzes the fiction and structure of genomes. Genomics uses DNA sequencing to decode and analyze genomes. Gene sequencing is a useful tool for cancer diagnostic and various other infectious diseases. Recent medicine trends and collaborations of the healthcare industry with regulatory authorities for genome sequencing would support and expand genomic sequencing practices around the globe. Moreover, public and private funding for the development of genomic research is also likely to support market growth. This favorable scenario creates an opportunity for the metagenomic sequencing market.

Some of the major genome mapping and funding programs supporting the market growth include,

In 2016, the government of France announced a program, namely, the “Medecine Genomique 2025”. This program aims to open 12 genome sequencing centers in France.In 2017, XIFIN Inc. launched the next-generation sequencing module. This module delivers advanced workflow functionality for laboratory sequencing operations and precision medicine.National Human Genome Research Institute (NHGRI) in 2019, awarded USD 2.5 million to Washington University in St. Louis (WashU), University of California, Santa Cruz (UCSC), and the European Bioinformatics Institute (EBI), which will coordinate with the National Center for Biotechnology Information, to form the WashU-UCSC-EBI Human Genome Reference Center. This center aims to provide a next-generation reference sequence of the human genome as a resource for the scientific community and support interactions within the genomics community.In 2018, All of Us Research Program, a part of the National Institutes of Health, awarded funds over USD 28.6 million to establish three genome centers in the US. These centers will produce genome data for researchers and program’s precision medicine research platform, a national resource to support studies on a variety of important health questions.

Market Opportunities

Many companies face challenges in storing the sequencing test data. The genome sequencing technology produces a large volume of sequencing data during the research activity. Large data creates storage challenges for the operator. The cloud-based technology helps resolve the storage issue in sequencing data. Cloud-based solutions are used for data storage, effective data management, and analysis of the large volume of data. This advantage helps companies to focus on cloud-based technology. Cloud-based solutions create an opportunity for companies to develop and capture the maximum share in the metagenomic sequencing market. Recently in January 2018, Illumina launched BaseSpace Sequence in China. It is a cloud-based solution used for genomic data storage and analysis of samples.

This cloud-based technology acts as an opportunity for the growth of the metagenomic sequencing market

Market Restraints

Reimbursement policies for genome sequencing testing vary widely among private and public insurers. The availability of funding and reimbursement is only for the FDA approved NGS tests, which are performed in laboratories. The reimbursement is not applicable for genome sequencing tests, which are not approved by the FDA. Recently, the Centers for Medicare and Medicaid Services finalized the National Coverage Determination to cover only FDA approved diagnostic laboratory tests used for genome sequencing for patients who have advanced cancer.

This unfavorable reimbursement policy impacts on implementation and adoption of genome sequencing testing performed in laboratories. The testing cost is a major barrier to the implementation of genome sequencing testing. Due to the high cost of genome sequencing testing, it is still not affordable for patients. These unfavorable regulatory policies towards genome sequencing tests would restrain the metagenomic sequencing market during the forecast period.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2027)

Value (USD Mn)

Reagents & Consumables

Services

Instruments

Analysis and Data Interpretation Solutions

Companies

Key companies profiled in Metagenomic Sequencing Market

Profiles of 108 companies operating in the Metagenomic Sequencing Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 108 of 108 companies

BGI

Healthcare

Company Headquarters: Shenzhen, China Founded: 1999 Workforce: ~3150 Company Working: BGI is a publicly listed commercial genomics company. It is one of the leading life science and genomics organizations. The company has world-leading bio-informatics research and development, large scale computing infrastructure for data output and storage, and proprietary sequencing platforms. It operates through molecular genetics, sequencing services, mass spec, and pharma solutions. It offers a wide range of integrated genomic and proteomic services and solutions for medical institutions, research institutions, and other public and private partners. BGI offers its genomics and proteomics services in research areas, such as cancer, metagenomics, drug discovery, reproductive health, and biomarker discovery. It has a presence in more than 100 countries and regions around the world and has a large network of service laboratories in China, Hong Kong, the US, and Europe.

Company Headquarters: Germany, Europe Founded: 1984 Workforce: 5,000 Company Working: Qiagen is a healthcare company that deals in sample and assay technologies for molecular diagnostics. The company operates through more than 35 offices spread in over 25 countries. It serves more than 500,000 customers across the globe. Its product portfolio spans through a full range of molecular testing applications. Qiagen’s products are used for extraction, purification, and stabilization of DNA, RNA, and protein from various biological samples. It has over 500 core products in its portfolio. The company is listed on the New York Stock and Frankfurt Prime Standard exchanges. It offers its products in various areas such as discovery & translational research, diagnostics & clinical research, next-generation sequencing, and instruments & automation.

Eurofins Scientific

Company Headquarters: Luxembourg Founded: 1987 Workforce: 45,000 Company Working: Eurofins Scientific is a leader in analytical testing services that provides clinical tests and laboratory services in drug discovery pharmacology, genomics, forensics, contract manufacturing organization (CMO), advanced material sciences, and for supporting clinical studies across multiple industries. Pharmaceutical, environment, food, and cosmetics are the major clients for Eurofins Scientific’s products. The company has around 800 laboratories across 47 countries. It has a portfolio of over 200,000 analytical methods to evaluate and identify the safety, composition, authenticity, purity, and origin of biological substances and products, also used in clinical diagnostics. Geographically, the company operates in North America and South America, Europe, and Asia-Pacific.

PerkinElmer Inc

Company Headquarters: US Founded: 1937 Workforce: ~13,000 Company Address: PerkinElmer Inc, 331 Treble Cove Rd, Billerica, Massachusetts, 01862 US. Contact Details: Product Sales: California (1-408-232-0653); Puerto Rico (1-787 783 3067); Connecticut (1-203-905-4600); Investor Relation Contact (ir@perkinelmer.com Tel: (781) 663 6900, Address: 940 Winter Street, Waltham, MA 02451 US) Company Working: PerkinElmer Inc (PerkinElmer) is largely engaged in providing solutions to diagnostics, delivery, and analytical solutions markets. The company deals in creating innovative solutions for better and fast diagnosis of various health issues worldwide. It pioneers in scientific technologies for better detection, imaging, and informatics. The company serves its customers in over 150 countries. PerkinElmer has nearly 3,500 patents active and operates in clinical research, life sciences, food, environmental, and industrial markets.

Novogene Corporation

Company Headquarters: Beijing, China Founded: 2011 Workforce: ~2,600 Company Working: Novogene Corporation (Novogene) is a leading provider of genomic services and solutions with cutting edge bioinformatics expertise. The company focuses on genome research and bioinformatics development. It offers genomic solutions in which the sequencing and assembly of whole genomes for variation detection, population evolution, genetic map, and functional gene mapping. The company owns 27 NGS-related patents, as well as the publishing of over 4,920 customer research papers in publications such as Nature and Science. Its genomic sequencing labs are present in the US, the UK, and China. Additionally, Novogene has a genomic center in Singapore in partnership with AIGbiotech, a biotechnology company in Singapore. It has advanced NGS capacity and serves 4,000 customers worldwide.

Company Headquarters: New Jersey, US Founded: 1999 Workforce: ~500-1000 Company Working: GENEWIZ is a global leader in the research and development of genomic services. It is committed to performing research activities through fast, reliable delivery of quality results, competitive prices, excellent project management, and easy access to expert technical support. The company offers a variety of genomic services, including Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next-generation sequencing, bioinformatics, and GLP regulatory services. It has a growing network of genomic laboratories globally, including the US, the UK, and China. It provides solutions and services compliant with the Good Laboratory Practice (GLP), Clinical Laboratory Improvement Amendments (CLIA) regulations, and College of American Pathologist (CAP) standards. It won different industry awards, including the Frost & Sullivan 2016 North America Life Science Research Services Company of the Year Award.

Page 1 of 18

…

Go to page

About the Author

Biotechnology Research Team

Healthcare · Biotechnology

Wantstats' healthcare coverage comes from a small, focused team that spends as much time talking to clinicians and payers as it does modeling data. What's in this report reflects that mix — grounded in proprietary market data, cross-checked against public filings, and reviewed internally before publication. This report specifically covers the Biotechnology space within that portfolio.

Similar Reports

View all

HealthcareJul 31, 2026

Vietnam Oncology Drugs Market

HealthcareJul 31, 2026

US Occupational Medicine Market

HealthcareJul 31, 2026

US Occupational Health Market

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Metagenomic Sequencing Market

By Segment, By Region, And Segment Forecasts, 2016 – 2027

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Metagenomic Sequencing Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Metagenomic Sequencing Market — Competitive Analysis

Regional Market Data

Segment Revenue (2027)

Segment Market Share

Market by Segment (2027)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2027)

About the Author

Biotechnology Research Team

Market Performance Trend

Metagenomic Sequencing Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Metagenomic Sequencing Market — Competitive Analysis

Regional Market Data

Segment Revenue (2027)

Segment Market Share

Market by Segment (2027)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2027)

About the Author

Biotechnology Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription